MedPath

Preventing Type 2 Diabetes in Black Emergent Adult

Not Applicable
Not yet recruiting
Conditions
Type 2 Diabetes Mellitus
Binge-Eating Disorder
Binge Eating
Obesity
Registration Number
NCT06848244
Lead Sponsor
University of North Carolina, Chapel Hill
Brief Summary

Black Americans are disproportionately affected by diabetes, with nearly double the rates of type 2 diabetes mellitus (T2DM), compared to non-Hispanic White adults. Though numerous factors affect these disparities, one modifiable risk factor may be that of binge eating (BE), which increases risk for binge-eating disorder (BED), which is associated with severe obesity, and often precedes a T2DM diagnosis, beginning in childhood or adolescence. Nearly 30% of Black women with obesity report binge eating episodes. Furthermore, given that binge and overeating may disparately increase the odds of obesity in Black adults (15-fold increase vs. 6-fold increase in White adults), reducing this behavior will be critical to prevent continued disparities in T2DM diagnosis. Given that Black women have the highest rates of obesity in the nation (57%), report disparate rates of weight gain between young adulthood and mid adulthood, and report disparate rates of emotional eating in adolescence, which is a risk factor for BE, one pathway to reducing disparities in T2DM risk in Black women may be to reduce binge eating and prevent weight gain in emerging adulthood (ages 18-25).

Detailed Description

Aim 1. Use formative research to gather recommendations to Tailor AAT+DPP to Black Emergent Adult (EA) Women (Year 1).

Aim 2. Utilize community-engaged and user-centered design methods to adapt a mobile intervention to prevent T2DM in Black women at risk for BED (Year 2).

Aim 3. Conduct a pilot randomized trial to examine the feasibility and acceptability, and preliminary efficacy of the adapted AAT+ DPP intervention (Years 3-4; Analysis Year 5).

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • Black women
  • between 18-25 years of age
  • BMI ≥ 25 kg/m^2
  • At least one binge eating episode weekly
  • Prediabetic
  • Have access to a smartphone
Exclusion Criteria
  • Have no internet access
  • Currently type 2 diabetic
  • Currently pregnant
  • Are in substance use treatment
  • Have received prior or planned bariatric surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in number of Binge Eating Episodes from Baseline to Month 6Baseline, 6 months

Participants will self-monitor and complete surveys on binge eating episodes.

Change from Baseline to Month 6 in weight regainBaseline, 6 months

Participant body weight will be measured by trained research staff using calibrated digital scales. Participants will be in light indoor clothing, with pockets emptied, and belts and shoes removed.

Secondary Outcome Measures
NameTimeMethod
Change in Inflammatory Biomarkers for T2DM from Baseline to Month 6Baseline, 6 months

Participants will provide plasma samples to examine the risk for type 2 diabetes mellitus.

Trial Locations

Locations (1)

UNC-Chapel Hill

🇺🇸

Chapel Hill, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath